| Market Cap | 556.74K | P/E | 0.58 | EPS this Y | - | Ern Qtrly Grth | - |
| Income | 850k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 16.00% |
| Sales | 726k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -1.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -61.00% |
| Recommedations | - | Quick Ratio | 0.14 | Shares Outstanding | 48.10M | 52W Low Chg | 16.00% |
| Insider Own | 22.02% | ROA | -68.18% | Shares Float | 35.55M | Beta | 1.97 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | 5.86K/- | Price | 0.01 |
| Gross Margin | -20.25% | Profit Margin | 117.08% | Avg. Volume | 51,798 | Target Price | - |
| Oper. Margin | -129.27% | Earnings Date | - | Volume | 1,350 | Change | 0.00% |
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.
